AnPac Bio-Medical Science Co., Ltd Earning Date (ANPC)

USA |NASDAQ |USD |ADR

ANPC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Dec 31, 2021 - $-0.34 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Dec 31, 2021 - - -

ANPC Earnings Date & History Chart

ANPC Earnings & Revenue Forecast

ANPC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.67 $-0.67 $-0.67

ANPC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.67 $-0.67 $-0.67

ANPC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $5.40M $5.40M $5.40M

ANPC Earnings Date & Revenue History

ANPC Earnings History

|
Show More
Show More

ANPC Revenue History

|
Show More
Show More

Anpac Bio-Medical Science Co., Ltd Next Earnings Date & Report

ANPC Oct 2021 (FQ) Earnings Date & Report Preview

Anpac Bio-Medical Science Co., Ltd Previous Earnings Dates & Reports

ANPC Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Anpac Bio-Medical Science Co., Ltd's previous earnings date was Oct 12, 2021 for its fiscal quarter ended Sep 30, 2021.

ANPC's earnings per share (EPS) was $-0.34, missing the consensus analysts forecast of $-0.13 by -161.54%.

ANPC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Revenues were $20.51M, better than the forecast of $3.14M by 552.53%, and up by 89.11% from previous year's revenue.

The company reported a net income of $-80.47M.

Anpac Bio-Medical Science Co., Ltd reported a free cash flow of $-61.46M for its fiscal year, compared to $-51.76M a year ago.

The company ended the fiscal year with $8.23M in total debt, a decrease of -78.66% compared to the previous year.